Chlordiazepoxide Hydrochloride Capsule
Product Images NDC 70518-0015

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride (NDC 70518-0015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlordiazepoxide HCl 25mg 70518 0015 00

Label for Chlordiazepoxide Hydrochloride 25 mg capsules, quantity 30, repackaged by RemedyRepack Inc. The label includes the NDC number 70518-0015-00, classification as a Schedule IV controlled substance, manufacturer information for Teva in Frazer, PA, and standard cautionary statements about federal law and storage temperature recommendations.*

FDA Label Image

Images 1

Chemical structure of Chlordiazepoxide Hydrochloride depicting its molecular framework with a chlorinated benzene ring, diazepine ring, and associated atoms, along with the hydrochloride (HCl) component indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.